Manufacturers Life Insurance Company, The Entrada Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 56,855 shares of TRDA stock, worth $764,131. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,855
Previous 57,098
0.43%
Holding current value
$764,131
Previous $813,000
11.81%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding TRDA
# of Institutions
103Shares Held
28.1MCall Options Held
34.5KPut Options Held
16.4K-
Baker Bros. Advisors LP New York, NY4.87MShares$65.4 Million0.83% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.43MShares$59.5 Million48.7% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$59.2 Million28.09% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.05MShares$41 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.71MShares$23 Million0.01% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $422M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...